Because mTOR is a key molecule downstream of the PI3K pathway that regulates cell growth, proliferation, and survival, we tested whether an mTOR inhibitor, rapamycin, could overcome the lapatinib resistance in CSK-null and PTEN-null GC cells. Here, PIK3CB is linked to gastric cancer.